# Phase 1 Hepatitis B trials recruiting: 21 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials in phase 1 for Hepatitis B that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 Hepatitis B trials: 21 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/hepatitis-b

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 21
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07944482 | A Study on the Pharmacokinetics and Safety of GST-HG141 Tablets in Participants With Hepatic Impairment and Normal Liver Function | Fujian Akeylink Biotechnology Co., Ltd. | Phase 1 | Recruiting | Chronic Hepatitis b | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944482) |
| October 29, 2026 | NCT07905157 | A Study to Compare Blood Levels of Bepirovirsen and Safety Using Different Methods of Injecting in Healthy Adult Participants | GlaxoSmithKline | Phase 1 | Not yet recruiting | Hepatitis B | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07905157) |
| October 29, 2026 | NCT07903831 | Phase Ia/Ib Trial of SCTA02A Injection in Healthy Adults and Patients With Chronic Hepatitis B | Sinocelltech Ltd. | Phase 1 | Not yet recruiting | Hepatitis B | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903831) |
| October 21, 2026 | NCT07884864 | A Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) Participants | Ausper Biopharma Co., Ltd. | Phase 1 | Not yet recruiting | Chronic Hepatitis B Virus | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884864) |
| June 1, 2026 | NCT07617194 | Study of AHB-171 in Chronic Hepatitis B Participants | AusperBio Therapeutics Inc. | Phase 1 | Not yet recruiting | Hepatitis B, Chronic | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07617194) |
| May 22, 2026 | NCT07600788 | A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver... | Ausper Biopharma Co., Ltd. | Phase 1 | Recruiting | Chronic Hepatitis B | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07600788) |
| May 15, 2026 | NCT07589400 | Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated... | Xiamen Amoytop Biotech Co., Ltd. | Phase 1 | Not yet recruiting | Metabolic Dysfunction-associated Steatotic Liver Disease, Chronic Hepatitis b | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07589400) |
| April 6, 2026 | NCT07511218 | A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants | Ausper Biopharma Co., Ltd. | Phase 1 | Recruiting | Chronic Hepatitis B Infection | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07511218) |
| February 5, 2026 | NCT07389044 | A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B | IntegerBio | Phase 1 | Recruiting | Chronic Hepatitis B Virus Infection | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07389044) |
| December 10, 2025 | NCT07275918 | SA1211 Injection Phase 1 Study | Suzhou Siran Biotechnology Co.,Ltd. | Phase 1 | Recruiting | Chronic Hepatitis B | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07275918) |
| July 4, 2025 | NCT07051187 | A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection | Sponsor not shown (see the record) | Phase 1 | Recruiting | Chronic Hepatitis B Virus (Hbv) | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07051187) |
| June 17, 2025 | NCT07024641 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection | GigaGen, Inc. | Phase 1 | Recruiting | Hepatitis B Virus Infection | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07024641) |
| March 20, 2025 | NCT06885710 | HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients | Changhai Hospital | Phase 1 | Recruiting | Chronic Hepatitis b | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06885710) |
| January 29, 2025 | NCT06800131 | Hepatitis B Vaccine Delivered Trans-dermally by MAP | International Vaccine Institute | Phase 1 | Not yet recruiting | Hepatitis B Vaccine | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06800131) |
| November 8, 2024 | NCT06680232 | Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B | Precision BioSciences, Inc. | Phase 1 | Recruiting | HEPATITIS B CHRONIC | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06680232) |
| November 4, 2024 | NCT06671093 | Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B | Tune Therapeutics, Inc. | Phase 1 | Recruiting | Chronic Hep B, Chronic Hepatitis b, Chronic Hepatitis, HBV | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06671093) |
| October 31, 2024 | NCT06668727 | Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study) | Aarhus University Hospital | Phase 1 | Recruiting | Hepatitis B | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06668727) |
| October 28, 2024 | NCT06661148 | Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients | Epigenic Therapeutics, Inc | Phase 1 | Not yet recruiting | Chronic Hepatitis B, HBV (Hepatitis B Virus) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06661148) |
| April 14, 2021 | NCT04843852 | TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B | University of Maryland, Baltimore | Phase 1 | Recruiting | Hepatitis B, Chronic Hepatitis B | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04843852) |
| February 9, 2021 | NCT04745403 | Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV) | Lion TCR Pte. Ltd. | Phase 1 | Recruiting | Hepatocellular Carcinoma | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04745403) |
| February 1, 2019 | NCT03826433 | hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis | Sclnow Biotechnology Co., Ltd. | Phase 1 | Recruiting | Hepatitis B | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03826433) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Ausper Biopharma Co., Ltd. | 3 |
| AusperBio Therapeutics Inc. | 1 |
| GigaGen, Inc. | 1 |
| [Xiamen Amoytop Biotech Co., Ltd.](https://specstream.ai/data/clinical-trials/company/xiamen-amoytop-biotech-co-ltd) | 1 |
| Changhai Hospital | 1 |
| Suzhou Siran Biotechnology Co.,Ltd. | 1 |
| [Sinocelltech Ltd.](https://specstream.ai/data/clinical-trials/company/sinocelltech-ltd) | 1 |
| Tune Therapeutics, Inc. | 1 |
| Lion TCR Pte. Ltd. | 1 |
| Epigenic Therapeutics, Inc | 1 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 1 |
| Sclnow Biotechnology Co., Ltd. | 1 |
| Precision BioSciences, Inc. | 1 |
| IntegerBio | 1 |
| University of Maryland, Baltimore | 1 |
| Aarhus University Hospital | 1 |
| Fujian Akeylink Biotechnology Co., Ltd. | 1 |
| International Vaccine Institute | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 11 |
| Hong Kong | 5 |
| New Zealand | 5 |
| United States | 3 |
| Moldova | 3 |
| Australia | 2 |
| South Korea | 1 |
| Taiwan | 1 |
| Singapore | 1 |
| France | 1 |
| Romania | 1 |
| Ukraine | 1 |
| Denmark | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Laser cutting companies in the United States](https://specstream.ai/data/businesses/laser-cutting-companies/united-states)
- [Property management companies in the United States](https://specstream.ai/data/businesses/property-management-companies/united-states)
- [Veterans hospitals in the United States](https://specstream.ai/data/businesses/veterans-hospitals/united-states)
- [Building contractors in the United States](https://specstream.ai/data/businesses/building-contractors/united-states)
- [Eye care clinics in the United States](https://specstream.ai/data/businesses/eye-care-clinics/united-states)
- [Lebanese restaurants in the United States](https://specstream.ai/data/businesses/lebanese-restaurants/united-states)
